BioSpace News Archive

Fact.MR, a market research and competitive intelligence provider: Sales in the global medical superabsorbent polymers market are expected to surpass US$ 5.66 Bn by 2032, as per a detailed study published by Fact.MR.

Surge in the adoption of advanced technologies such as artificial intelligence across the healthcare sector and growing support by several government authorities for digitalization are some of the prime factors boosting the expansion of the global digital transformation in healthcare market during the forecast period of 2021 to 2031.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Dental burs are important tools for nearly every dental treatment and procedure.

Wilmington, Delaware, United States, Transparency Market Research Inc.: 5G is a widely popular nomenclature for the emerging and fifth generation of mobile and telecommunications technology.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Mobile imaging technology is utilized to give quick, exact analytic administrations on-site, changing a traditionally tedious interaction into a smooth, simple one with prompt outcomes.

Fact.MR, a market research and competitive intelligence provider, mentions that the global medical foam market would be worth US$ 27 Bn in 2022 and grow at the rate of 4% between 2022 and 2032.

Sequana Medical NV announces the completion of enrollment in its Phase 2a SAHARA proof-of-concept study using its first-generation DSR product as treatment for congestive heart failure.

For decades, the treatment for a young child with a broken femur has been the same: a surgically placed spica cast, commonly known as a body cast.

CN Bio, a leading Organ-on-a-chip Company that designs and manufactures single-and multi-organ microphysiological systems, announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services.

Ribbon Biolabs announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 2020283756 A1, covering Ribbon Biolabs’ novel method for synthesizing a double stranded polynucleotide, also known as DNA, using a diverse library of oligonucleotides.